Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New Mexico
Frontiers in Public Health June 17, 2026 Lawrence Leeman, Maya Armstrong, Dara Menashi et al.
A community-informed, open-label feasibility study will test group psilocybin-assisted therapy for PTSD using whole psilocybin mushrooms. The protocol includes six groups of six participants—veterans, first responders, and women survivors of sexual violence—who will receive two doses (20 mg and 30 mg) of psilocybin in chocolate, combined with group and individual therapy. Outcomes will measure safety, feasibility, and PTSD symptoms using standard scales. A parallel micro-costing analysis will capture delivery costs for community engagement, therapy, and extended integration. The study aims to ensure access and trust for populations facing structural barriers.